Literature DB >> 23009284

Factors associated with the presence of multiple Lugol-voiding lesions in patients with esophageal squamous-cell carcinoma.

C Katada1, M Muto, S Tanabe, K Higuchi, T Sasaki, M Azuma, K Ishido, N Katada, S Sakuramoto, K Yamashita, T Masaki, M Nakayama, M Okamoto, W Koizumi.   

Abstract

Multicentric squamous dysplasia of the esophagus is characterized by multiple Lugol-voiding lesions (LVLs) on Lugol chromoendoscopy. Multiple LVLs are associated with a very high risk of multiple cancers arising in the esophagus as well as the head and neck. To gain insight into the pathogenesis of multiple LVLs of the esophageal mucosa, we studied risk factors for the development of such lesions in 76 patients who had a current or previous diagnosis of esophageal squamous cell carcinoma. All patients underwent Lugol chromoendoscopy of the esophageal mucosa. The history of tobacco and alcohol use was documented. Polymorphisms of the aldehyde dehydrogenase type 2 (ALDH2) gene were identified by polymerase chain reaction using sequence-specific primers. Clinical factors related to multiple LVLs were analyzed. All patients with multiple LVLs were drinkers. On univariate analysis, male sex (odds ratio [OR] 15, 95% confidence interval [CI] 1.84-122.45: P = 0.011), presence of the ALDH2-2 allele (OR 4.5, 95% CI 1.55-13.24: P = 0.006), and smoking index ≥1000 (OR 2.6, 95% CI 1.02-6.6: P = 0.045) were associated with multiple LVLs. On multivariate analysis, male sex (OR 10.02, 95% CI 1.13-88.44: P = 0.038) and presence of the ALDH2-2 allele (OR 4.56, 95% CI 1.4-14.82: P = 0.012) were associated with multiple LVLs. Among drinkers, a daily alcohol intake of ≥100 g pure ethanol with the ALDH2-2 allele (OR 17.5, 95% CI 1.97-155.59: P = 0.01) and a daily alcohol intake of <100 g pure ethanol with the ALDH2-2 allele (OR 8.85, 95% CI 1.68-46.69: P = 0.01) more strongly correlated with multiple LVLs than did a daily alcohol intake of <100 g pure ethanol without the ALDH2-2 allele, whereas a daily alcohol intake of ≥100 g pure ethanol without the ALDH2-2 allele (OR 4.0, 95% CI 0.54-29.81: P = 0.18) did not. In conclusion, male sex and the ALDH2-2 allele are associated with an increased risk for multiple LVLs of the esophageal mucosa in patients with esophageal squamous cell carcinoma. Among drinkers with the ALDH2-2 allele, the risk of multiple LVLs increased in parallel to the daily alcohol intake.
© 2012 Copyright the Authors. Journal compilation © 2012, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Keywords:  ALDH2; esophageal cancer; multiple LVL

Mesh:

Substances:

Year:  2012        PMID: 23009284     DOI: 10.1111/j.1442-2050.2012.01429.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  7 in total

1.  Association between macrocytosis and metachronous squamous cell carcinoma of the esophagus after endoscopic resection in men with early esophageal squamous cell carcinoma.

Authors:  Chikatoshi Katada; Tetsuji Yokoyama; Tomonori Yano; Ichiro Oda; Yuichi Shimizu; Hisashi Doyama; Tomoyuki Koike; Kohei Takizawa; Motohiro Hirao; Hiroyuki Okada; Takako Yoshii; Yutaro Kubota; Takenori Yamanouchi; Takashi Tsuda; Tai Omori; Nozomu Kobayashi; Haruhisa Suzuki; Satoshi Tanabe; Keisuke Hori; Norisuke Nakayama; Hirofumi Kawakubo; Naomi Kakushima; Yasumasa Matsuo; Hideki Ishikawa; Akira Yokoyama; Manabu Muto
Journal:  Esophagus       Date:  2019-07-08       Impact factor: 4.230

2.  Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502.

Authors:  Seiichiro Mitani; Ken Kato; Hiroyuki Daiko; Yoshinori Ito; Isao Nozaki; Takashi Kojima; Masahiko Yano; Satoru Nakagawa; Masaki Ueno; Masaya Watanabe; Shigeru Tsunoda; Tetsuya Abe; Shigenori Kadowaki; Tomohiro Kadota; Keita Sasaki; Ryunosuke Machida; Yuko Kitagawa
Journal:  J Gastroenterol       Date:  2022-05-11       Impact factor: 6.772

3.  Prognostic factors after transoral resection of early hypopharyngeal cancer.

Authors:  Keisuke Iritani; Daryl Anne A Del Mundo; Shinobu Iwaki; Kuriko Masuda; Maki Kanzawa; Tatsuya Furukawa; Masanori Teshima; Hirotaka Shinomiya; Koichi Morimoto; Naoki Otsuki; Ken-Ichi Nibu
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-07-17

4.  Endoscopic screening using esophageal iodine staining and genotypes of ADH1B and ALDH2 in Japanese alcohol-dependent women.

Authors:  Akira Yokoyama; Tetsuji Yokoyama; Tai Omori; Hitoshi Maesato; Tsuyoshi Takimura; Chie Iwahara; Mitsuru Kimura; Toshifumi Matsui; Takeshi Mizukami; Katsuya Maruyama
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

5.  Protective effects of Alda-1, an ALDH2 activator, on alcohol-derived DNA damage in the esophagus of human ALDH2*2 (Glu504Lys) knock-in mice.

Authors:  Kenshiro Hirohashi; Shinya Ohashi; Yusuke Amanuma; Yukie Nakai; Tomomi Ida; Kiichiro Baba; Yosuke Mitani; Ayaka Mizumoto; Yoshihiro Yamamoto; Osamu Kikuchi; Junichi Matsubara; Atsushi Yamada; Shin'ichi Miyamoto; Hiroshi Seno; Tomonari Matsuda; Manabu Muto
Journal:  Carcinogenesis       Date:  2020-04-22       Impact factor: 4.944

Review 6.  Endoscopic diagnosis and treatment of early esophageal squamous neoplasia.

Authors:  Yuto Shimamura; Takashi Ikeya; Norman Marcon; Jeffrey D Mosko
Journal:  World J Gastrointest Endosc       Date:  2017-09-16

Review 7.  Alcohol Consumption, ALDH2 Polymorphism as Risk Factors for Upper Aerodigestive Tract Cancer Progression and Prognosis.

Authors:  Che-Hong Chen; Wen-Lun Wang; Ming-Hung Hsu; Daria Mochly-Rosen
Journal:  Life (Basel)       Date:  2022-02-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.